Fig. 1From: Dipyridamole and adenosinergic pathway in Covid-19: a juice or holy grailAdenosinergic pathway and the contribution of DIP in Covid-19. DIP inhibits SARS-CoV-2 replication, platelet activation, PDE, ENT-1, and macrophages activation with activation of AD. ADK and ADA metabolize AD. SARS-CoV-2 activates ADA-BP on DPP-4 and inhibits ADBack to article page